Table 3.
HR | P values | 95% CI | |
Control group/TAVI by number of comorbidities (reference: control group, 6 or more comorbidities) | |||
Control group (up to five comorbidities) | 0.48 | <0.001 | 0.34 to 0.69 |
TAVI (up to five comorbidities) | 0.23 | 0.004 | 0.09 to 0.63 |
TAVI (six or more comorbidities) | 0.99 | 0.93 | 0.71 to 1.36 |
Female (ref: male) | 0.72 | 0.020 | 0.55 to 0.95 |
Age (ref: 75–79 years) | |||
80–84 | 1.24 | 0.242 | 0.86 to 1.79 |
85–89 | 1.74 | 0.005 | 1.18 to 2.56 |
90+ | 2.67 | 0.001 | 1.48 to 4.81 |
n=915, LR (likelihood ratio test)=42.2; p<0.001.
TAVI, transcatheter aortic valve implantation.